Transaction in Own Shares

Summary by AI BETAClose X

Hikma Pharmaceuticals Plc has executed a portion of its $250 million share repurchase program, buying back a total of 247,630 ordinary shares between March 30 and April 2, 2026, for approximately £3.1 million. The company has now repurchased a cumulative 3,994,124 shares for £49.8 million since the program's inception on February 26, 2026. Following these transactions, Hikma holds 12,833,233 shares in treasury, with 217,892,329 ordinary shares currently in issue.

Disclaimer*

UK 100

Latest directors dealings